Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Filings indexed 1,740 across all filing types
Latest filing 2022-09-02 Regulatory Filings
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
本公司新產品CGM「連續性監控血糖儀」已取得台灣醫院 臨床試驗報告。
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (華廣生技股份有限公司) reporting that their new product CGM has completed clinical trials and obtained a clinical trial report. It includes the date of the event and the company's planned next steps for regulatory submission. The document is brief (691 characters) and does not contain any financial data, detailed financial statements, or comprehensive report content. It is an announcement of a factual event related to product development and regulatory progress, not a financial report or management discussion. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any financial filings. It is also not a regulatory certification or officer attestation. Given the nature and length, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-09-02 Chinese
本公司受邀參加德信證券舉辦之線上法說會
Investor Presentation Classification · 90% confidence The document is a brief announcement about the company (華廣) participating in an online investor presentation hosted by 德信證券. It includes details such as the date, time, and nature of the event, mentioning that the company will explain its operational overview, financial, and business information. The document does not contain actual financial statements or detailed analysis but rather informs about the upcoming investor presentation event. The length is short (637 characters), and it serves as a notice of the event rather than the presentation materials themselves. Therefore, it fits the category of Investor Presentation (IP) announcement.
2022-09-02 Chinese
111年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes details such as capital amounts, investment methods, cumulative investment amounts, recognized investment gains or losses, and regulatory approval limits. The document is relatively short (1407 characters) and appears to be a regulatory disclosure of investment information rather than a full financial report or earnings release. There is no indication of it being an annual or quarterly report, audit report, or earnings release. It is a regulatory filing providing specific investment data as required by authorities, fitting best under the category of Regulatory Filings (RNS).
2022-08-12 Chinese
111年第2季海外子公司投資
Regulatory Filings Classification · 90% confidence The document is a financial disclosure related to investment holdings in overseas subsidiaries, showing investment amounts, ownership percentages, and recognized investment gains or losses for the current period. It is a tabular financial data report but very short (1001 characters) and does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure or a supplementary financial data update rather than a full financial report like an Annual Report (10-K) or Interim Report (IR). There is no indication of it being an announcement of a report publication or a certification. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-08-12 Chinese
111年第2季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed consolidated income statement data for the second quarter and half-year periods of the fiscal year 111 (which corresponds to 2022 in the Gregorian calendar). It includes comprehensive financial figures such as revenue, costs, expenses, operating profit, net profit, earnings per share, and other financial metrics. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is 3385 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2022-08-11 Chinese
111年第2季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the second quarter of the fiscal year 111 (which corresponds to 2022 in the Gregorian calendar). It includes detailed financial data such as cash flows from operating, investing, and financing activities, with specific amounts and accounting items. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 2351 characters, which is relatively short, but the content is detailed financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-08-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.